Related content

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P.   Butler P.   Shepperson N.B.   McHarg A.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET A receptor antagonist

By Yuyama H.   Sanagi M.   Koakutsu A.   Mori M.   Fujimori A.   Harada H.   Sudoh K.   Miyata K.  

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite

Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity

By Takeuchi H.   Yatsugi S.-i.   Hatanaka K.-i.   Nakato K.   Hattori H.   Sonoda R.   Koshiya K.   Fujii M.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 329, Iss. 1, 1997-06 ,pp. : 27-35

Elsevier

Access to resources Recommend Favorite

Investigation of the effects of YM-31636, a novel 5-HT 3 receptor agonist, on defecation in normal and constipated ferrets

By Ito H.   Kiso T.   Yuki H.   Naitoh Y.   Miyata K.   Iwaoka K.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 151-157

Elsevier

Access to resources Recommend Favorite

A novel 5-HT 3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain

By Kiso T.   Ito H.   Miyata K.   Kamato T.   Naitoh Y.   Iwaoka K.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 35-41

Elsevier

Access to resources Recommend Favorite